Form 4 Filing: Catalyst4, Inc. Buys shares of MapLight Therapeutics, Inc.

INSIDER PURCHASE

⚡ MATERIALITY: 8/10

corporate issuer

MapLight Therapeutics, Inc.

Ticker: not matched

Transaction Value

Not verified

Price/Share: not verified: company reports from abroad; currency could not be checked

transaction date

2026-07-30

Shares: 1,209,225

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Catalyst4, Inc., holds the title of 10% Owner at MapLight Therapeutics, Inc..

On 2026-07-30, the insider transacted 1,209,225 shares.The price in this filing could not be confirmed (company reports from abroad; currency could not be checked), so no dollar value is shown. The SEC filing has the figures as filed.

Executive Summary Summary

Catalyst4, Inc. (10% Owner) bought shares of $MLPT (value not verified)

Post-Transaction Position: 20,906,689 shares

SEC Accession No: 0001900201-26-000003 (CIK: 1900201)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

OpenCorporates RegistryVerify Corporate Identity

Google NewsMapLight Therapeutics, Inc. News Coverage